One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Table of Contents
doi : 10.1016/S1542-3565(23)00460-3
Volume 21, Issue 9, August 2023, Pages A11-A14
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(23)00461-5
Volume 21, Issue 9, August 2023, Pages A18-A20
Hepatic Inflammatory Pseudotumor-like Follicular Dendritic Cell Sarcoma Mimicking Hepatocellular Carcinoma
Hui-Hui Zhang,* Chang-Hui Xiao,* and Xian-Zheng Tan
doi : 10.1016/j.cgh.2022.12.023
Volume 21, Issue 9, August 2023, Pages A23-A24
Biodegradable Stenting in a Patient With a Refractory Biliary Stricture
Martha M. Kirstein, Carsten Engelke, and Philipp Solbach
doi : 10.1016/j.cgh.2023.01.026
Volume 21, Issue 9, August 2023, Pages A25-A26
Endoscopic Removal and Typical Presentation of Biliary Cast Formation
Yafei Zhang, Hongling Wang, and Qiu Zhao
doi : 10.1016/j.cgh.2023.01.030
Volume 21, Issue 9, August 2023, Pages A27-A28
Blue Notes
CHARLES J. KAHI, MD, MS,
doi : 10.1016/j.cgh.2023.05.020
Volume 21, Issue 9, August 2023, Pages 2167-2168
Breaking Barriers in Dietary Research: Strategies to Diversify Recruitment in Clinical Studies and Develop Culturally Tailored Diets for Hispanic Communities Living With Inflammatory Bowel Disease
ORIANA M. DAMAS ANA MALDONADO-CONTRERAS
doi : 10.1016/j.cgh.2023.05.006
Volume 21, Issue 9, August 2023, Pages 2169-2173
Health Advocacy, Policy, and Legislation for Gastroenterology Practices
Naser M. Khan, 1 Bruce Hennessy, 2 Michael Lajin, 3 Husna Qazi, 1 and Lukejohn Day
doi : 10.1016/j.cgh.2023.03.008
Volume 21, Issue 9, August 2023, Pages 2174-2177.e1
Management of Gastric Intestinal Metaplasia
Sheila D. Rustgi, 1,2,3 Haley M. Zylberberg, 1,2 Chin Hur, 1,2,3,§ and Shailja C. Shah
doi : 10.1016/j.cgh.2023.03.010
Volume 21, Issue 9, August 2023, Pages 2178-2182
Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference
Hashem B. El-Serag, 1 John W. Ward, 2 Sumeet K. Asrani, 3 Amit G. Singal, 4 Nicole Rich,4 Aaron P. Thrift, 5,6 Salil Deshpande, 7 Barbara J. Turner, 8 Ahmed O. Kaseb, 9 Ariel C. Harrison, 1 Brett E. Fortune, 10 and Fasiha Kanwal
doi : 10.1016/j.cgh.2023.03.029
Volume 21, Issue 9, August 2023, Pages 2183-2192
Therapeutic Drug Monitoring for Subcutaneous Infliximab? Too Early to Conclude
EDWARD V. LOFTUS, Jr.STEPHANE PAULXAVIER ROBLIN
doi : 10.1016/j.cgh.2022.12.028
Volume 21, Issue 9, August 2023, Pages 2193-2194
Carvedilol as Best β-Blocker for Secondary Prophylaxis of Variceal Bleeding: Are We There, or Not Yet?
JAUME BOSCH
doi : 10.1016/j.cgh.2022.08.026
Volume 21, Issue 9, August 2023, Pages 2195-2196
Efficacy of Elimination Diets in Eosinophilic Esophagitis: AÂ Systematic Review and Meta-analysis
Christoph Mayerhofer, 1 Anna Maria Kavallar, 1 Denise Aldrian, 1 Andrea Katharina Lindner, 2 Thomas Müller, 1 and Georg Friedrich Vogel
doi : 10.1016/j.cgh.2023.01.019
Volume 21, Issue 9, August 2023, Pages 2197-2210.e3
Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
Michael J. Buie, 1,2, * Joshua Quan, 2, * Joseph W. Windsor, 1,2 Stephanie Coward, 1,2 Tawnya M. Hansen, 3 James A. King, 4,5 Paulo G. Kotze, 6 Richard B. Gearry, 7 Siew C. Ng, 8 Joyce W. Y. Mak, 8 Maria T. Abreu, 9 David T. Rubin, 10 Charles N. Bernstein, 11 Rupa Banerjee, 12 Jesus K. Yamamoto-Furusho, 13 Remo Panaccione, 1 Cynthia H. Seow, 1,2 Christopher Ma, 1 Fox E. Underwood, 1,2 Vineet Ahuja, 14 Nicola Panaccione, 1 Abdel-Aziz Shaheen, 1,2 Jayna Holroyd-Leduc, 1,2 and Gilaad G. Kaplan, 1,2 on behalf of the Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group: Domingo Balderramo, 15 Vui Heng Chong, 16 Fabi?n Juliao-Ba?os, 17 Usha Dutta, 18 Marcellus Simadibrata, 19 Jamilya Kaibullayeva, 20 Yang Sun, 21,22 Ida Hilmi, 23 Raja Affendi Raja Ali, 24 Mukesh Sharma Paudel, 25 Mansour Altuwaijri, 26 Juanda Leo Hartono, 27 Shu Chen Wei, 28 Julajak Limsrivilai, 29 Sara El Ouali, 30 Beatriz Iade Vergara, 31 Viet Hang Dao, 32 Paul Kelly, 33,34 Phoebe Hodges, 33,34 Yinglei Miao, 21,22 and Maojuan Li
doi : 10.1016/j.cgh.2022.06.030
Volume 21, Issue 9, August 2023, Pages 2211-2221
Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-analysis
John Gubatan, 1, * Grant E. Barber, 1, * Ole Haagen Nielsen, 4 Carsten Bogh Juhl, 5,6 Cynthia Maxwell, 7 Michael L. Eisenberg, 2,3 and Sarah E. Streett
doi : 10.1016/j.cgh.2022.07.008
Volume 21, Issue 9, August 2023, Pages 2222-2238
Epidemiology and Healthcare Utilization in Patients With Gastroparesis: A Systematic Review
Saam Dilmaghani, Ting Zheng, and Michael Camilleri
doi : 10.1016/j.cgh.2022.07.011
Volume 21, Issue 9, August 2023, Pages 2239-2251.e2
Higher Body Mass Index Is Associated With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis
Corey J. Ketchem, 1 Adolfo A. Ocampo, 1 Zeyun Xue, 1 Nicole C. Chang, 1 Kisan P. Thakkar, 1 Sumana Reddy,1 Sydney B. Greenberg, 1 Christopher J. Lee, 1 Walker D. Redd, 1 Swathi Eluri, 1 Craig C. Reed, 1 and Evan S. Dellon
doi : 10.1016/j.cgh.2022.11.004
Volume 21, Issue 9, August 2023, Pages 2252-2259.e3
Clinical Relevance of Random Biopsies From the Esophagogastric Junction After Complete Eradication of Barrett’s Esophagus is Low
Charlotte N. Frederiks, 1,2, * Sanne N. van Munster, 1,3, * Esther A. Nieuwenhuis, 3 Lorenza Alvarez Herrero, 1 Alaa Alkhalaf, 4 Boudewijn E. Schenk, 4 Erik J. Schoon, 5 Wouter L. Curvers, 5 Arjun D. Koch, 6 Pieter-Jan F. de Jonge, 6 Thjon Tang, 7 Wouter B. Nagengast, 8 Jessie Westerhof, 8 Martin H. M. G. Houben, 9 Jacques J. G. H. M. Bergman, 3 Roos E. Pouw, 3 and Bas L. A. M. Weusten, 1,2 on behalf of the Dutch Barrett Expert Centers
doi : 10.1016/j.cgh.2022.11.012
Volume 21, Issue 9, August 2023, Pages 2260-2269.e9
The Surface Morphology of Large Nonpedunculated Colonic Polyps Predicts Synchronous Large Lesions
Timothy O’Sullivan, 1,2, * David Tate, 1,3,4, * Mayenaaz Sidhu, 1,2 Sunil Gupta, 1,2 James Elhindi, 6 Karen Byth, 5,6 Oliver Cronin, 1,2 Anthony Whitfield, 1,2 Ana Craciun, 7 Rajvinder Singh, 8 Gregor Brown,9,10 Spiro Raftopoulos, 11 Luke Hourigan, 12,13 Alan Moss, 14 Amir Klein, 15,16 Steven Heitman, 17,18,19 Stephen Williams, 1 Eric Lee, 1 Nicholas G. Burgess, 1,2 and Michael J. Bourke
doi : 10.1016/j.cgh.2023.01.034
Volume 21, Issue 9, August 2023, Pages 2270-2277.e1
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis
Mi Na Kim,1,2 Jae Seung Lee, 3,4 Hye Won Lee, 3,4 Beom Kyung Kim, 3,4 Jun Yong Park, 3,4 Do Young Kim, 3,4 Sang Hoon Ahn, 3,4 Se Young Jang, 5 Won Young Tak, 5 Young-Oh Kweon, 5 Soo Young Park, 5 and Seung Up Kim
doi : 10.1016/j.cgh.2022.10.035
Volume 21, Issue 9, August 2023, Pages 2278-2287.e5
Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era
Anjiya Shaikh, 1, * Karthik Goli, 2, * Tzu-Hao Lee, 3,4 Nicole E. Rich,5 Jihane N. Benhammou, 6 Stephanie Keeling, 2 Donghee Kim, 7 Aijaz Ahmed, 7 John Goss, 3 Abbas Rana, 3 Amit G. Singal, 5 Fasiha Kanwal, 3,8 and George Cholankeril 3
doi : 10.1016/j.cgh.2022.11.038
Volume 21, Issue 9, August 2023, Pages 2288-2297.e4
Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease
Ho Soo Chun, 1,2 Minjong Lee, 1,2 Hye Ah Lee, 3 Sejin Lee,4 Soyeon Kim, 4 Ye Jun Jung, 4 Chaewon Lee, 4 Hyoeun Kim, 5 Han Ah Lee, 1,2 Hwi Young Kim, 1,2 Kwon Yoo, 1,2 Tae Hun Kim, 1,2 Sang Hoon Ahn, 4,6 and Seung Up Kim
doi : 10.1016/j.cgh.2022.11.031
Volume 21, Issue 9, August 2023, Pages 2298-2307.e18
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
Benedikt Silvester Hofer, 1,2,3 Benedikt Simbrunner, 1,2,3 Lukas Hartl, 1,2 Mathias Jachs, 1,2 David Josef Maria Bauer, 1,2 Lorenz Balcar, 1,2 Rafael Paternostro, 1,2 Philipp Schwabl, 1,2,3 Georg Semmler, 1,2 Bernhard Scheiner, 1,2 Albert Friedrich Staettermayer, 1 Michael Trauner, 1 Mattias Mandorfer, 1,2 and Thomas Reiberger
doi : 10.1016/j.cgh.2022.11.033
Volume 21, Issue 9, August 2023, Pages 2308-2317.e7
Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis
Mathias Jachs, 1,2 Lukas Hartl, 1,2 Benedikt Simbrunner, 1,2,3 David Bauer, 1,2 Rafael Paternostro, 1,2 Lorenz Balcar, 1,2 Benedikt Hofer, 1,2,3 Nikolaus Pfisterer, 2,4 Michael Schwarz, 2,5 Bernhard Scheiner, 1,2 Albert F. St?ttermayer, 1 Matthias Pinter, 1 Michael Trauner, 1 Mattias Mandorfer, 1,2,§ and Thomas Reiberger
doi : 10.1016/j.cgh.2022.06.007
Volume 21, Issue 9, August 2023, Pages 2318-2326.e7
Healthcare Costs for Medicare Patients With Hepatocellular Carcinoma in the United States
Mohammad A. Karim, 1 Mahin Ramezani, 1 Todd Leroux, 2 Hye-Chung Kum, 1, * and Amit G. Singal 3,
doi : 10.1016/j.cgh.2022.11.015
Volume 21, Issue 9, August 2023, Pages 2327-2337.e9
Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study
Anthony Buisson, 1,2 Maria Nachury, 3 Maud Reymond, 1 Clara Yzet, 6 Pauline Wils, 3 Laure Payen, 1 Marie Laugie, 1 Luc Manlay, 1 Nicolas Mathieu, 4 Bruno Pereira, 5 and Mathurin Fumery
doi : 10.1016/j.cgh.2022.08.011
Volume 21, Issue 9, August 2023, Pages 2338-2346.e3
Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment
Edward V. Loftus Jr., 1 Jean-Frederic Colombel, 2 Ken Takeuchi, 3 Xiang Gao, 4 Remo Panaccione, 5 Silvio Danese, 6 Marla Dubinsky, 7 Stefan Schreiber, 8 Dapo Ilo, 9 Tricia Finney-Hayward, 10 Wen Zhou, 9 Charles Phillips, 9 Yuri Sanchez Gonzalez, 9 Lei Shu, 9 Xuan Yao, 9 Qing Zhou, 9 and Séverine Vermeire
doi : 10.1016/j.cgh.2022.11.029
Volume 21, Issue 9, August 2023, Pages 2347-2358.e6
Comparative Safety and Effectiveness of Biologic Therapy for Crohn’s Disease: A CA-IBD Cohort Study
Siddharth Singh, 1,2 Jihoon Kim, 2 Jiyu Luo, 3 Paulina Paul, 2 Vivek Rudrapatna, 4 Sunhee Park, 5 Kai Zheng, 6 Gaurav Syal, 7 Christina Ha, 8 Phillip Fleshner, 9 Dermot McGovern, 7 Jenny S. Sauk, 10 Berkeley Limketkai, 10 Parambir S. Dulai, 11 Brigid S. Boland, 1 Samuel Eisenstein,12 Sonia Ramamoorthy, 12 Gil Melmed, 7 Uma Mahadevan, 4 William J. Sandborn, 1 and Lucila Ohno-Machado
doi : 10.1016/j.cgh.2022.10.029
Volume 21, Issue 9, August 2023, Pages 2359-2369.e5
Abdominal Bloating in the United States: Results of a Survey of 88,795 Americans Examining Prevalence and Healthcare Seeking
Janice E. Oh, 1 William D. Chey, 2 and Brennan Spiegel 1,3
doi : 10.1016/j.cgh.2022.10.031
Volume 21, Issue 9, August 2023, Pages 2370-2377
Up-Front Endoscopy Maximizes Cost-Effectiveness and Cost-Satisfaction in Uninvestigated Dyspepsia
Emily V. Wechsler, 1,2 Nitin K. Ahuja, 3 Darren Brenner, 4 Walter Chan, 5 Lin Chang, 6 William D. Chey, 7 Anthony J. Lembo, 8 Baha Moshiree, 9 Judy Nee, 8 Shailja C. Shah, 10 Kyle Staller, 11 and Eric D. Shah 1,
doi : 10.1016/j.cgh.2023.01.003
Volume 21, Issue 9, August 2023, Pages 2378-2388.e28
Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program
Molla M. Wassie, 1 Graeme P. Young, 1 Jean M. Winter, 1 Charles Cock, 1,2 Peter Bampton, 1 Mahadya Rahman, 3 Richard Heddle, 2 Robert Fraser, 2 Rosie Meng, 3 and Erin L. Symonds
doi : 10.1016/j.cgh.2022.12.024
Volume 21, Issue 9, August 2023, Pages 2389-2398.e2
Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of Testing
Jordan K. Voss, 1 Derek W. Ebner, 2 Keli N. Burger, 3 Douglas W. Mahoney, 3 Mary E. Devens, 2 Kari L. Lowrie, 2 and John B. Kisiel
doi : 10.1016/j.cgh.2022.12.026
Volume 21, Issue 9, August 2023, Pages 2399-2406
Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center
NATHANIEL A. COHEN DAVID CHOI TENZIN CHODEN NOA KRUGLIAK CLEVELAND RUSSELL D. COHEN DAVID T. RUBIN
doi : 10.1016/j.cgh.2022.03.035
Volume 21, Issue 9, August 2023, Pages 2407-2409.e2
Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation
declineCAMERON GOFFANJIYA SHAIKHKARTHIK GOLIHASHEM B. EL-SERAGFASIHA KANWALGEORGE CHOLANKERIL
doi : 10.1016/j.cgh.2022.07.009
Volume 21, Issue 9, August 2023, Pages 2410-2412.e1
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction
FRITZ RUPRECHT MURRAYANDREA KREIENBUHL ALEX STRAUMANN LUC BIEDERMANN PHILIPP SCHREINER
doi : 10.1016/j.cgh.2022.07.007
Volume 21, Issue 9, August 2023, Pages 2413-2414
Empiric Pelvic Rehabilitation Delivered by Pelvic Floor Physical Therapists as an Up-Front Treatment for Chronic Constipation
ERIC D. SHAHMICHAEL A. CURLEYTRACY L. OSTLERAIMEE R. BURNETT GREELEYPABLO MARTINEZ-CAMBLORWILLIAM D. CHEY
doi : 10.1016/j.cgh.2022.07.023
Volume 21, Issue 9, August 2023, Pages 2415-2417
Recent Decline in the Incidence of Hepatocellular Carcinoma in the United States
AARON P. THRIFTKYLE S. LIUSYED AHSAN RAZAHASHEM B. EL-SERAG
doi : 10.1016/j.cgh.2022.07.034
Volume 21, Issue 9, August 2023, Pages 2418-2420.e3
Risk of Variceal Bleeding in Patients With Advanced Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab
YEONJUNG HA * JEE HYUN KIMJAEKYUNG CHEONGYEONG SIK JEONCHAN KIM HONG JAE CHON
doi : 10.1016/j.cgh.2022.07.035
Volume 21, Issue 9, August 2023, Pages 2421-2423.e2
Development and Validation of the Houston-BEST, a Barrett’s Esophagus Risk Prediction Model Adaptable to Electronic Health Records
THERESA NGUYEN WENKERJOEL H. RUBENSTEINAARON P. THRIFTHARDEEP SINGH
doi : 10.1016/j.cgh.2022.08.007
Volume 21, Issue 9, August 2023, Pages 2424-2426.e0
Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data
LEO BONESCHANSKER ASHWIN N. ANANTHAKRISHNAN
doi : 10.1016/j.cgh.2023.03.040
Volume 21, Issue 9, August 2023, Pages 2427-2429.e1
Can Subcutaneous Infliximab Replace Dose-Intensified Intravenous Administration in Inflammatory Bowel Disease?
ROBERT D. LITTLE MARK G. WARD MILES P. SPARROW
doi : 10.1016/j.cgh.2022.09.015
Volume 21, Issue 9, August 2023, Pages 2430-2431
Reply
ANTHONY BUISSONMARIA NACHURYMATHURIN FUMERY
doi : 10.1016/j.cgh.2022.11.006
Volume 21, Issue 9, August 2023, Pages 2431-2432
Similar Cure Rates With Different Routes: Can It Be Generalized?
TAHIR MAJEED BILAL AHMAD MIR ASHISH CHAUHAN
doi : 10.1016/j.cgh.2022.10.011
Volume 21, Issue 9, August 2023, Page 2432
Reply
BYRON P. VAUGHN ALEXANDER KHORUTS
doi : 10.1016/j.cgh.2022.11.011
Volume 21, Issue 9, August 2023, Page 2433
Concentrating on the Long Topic of Empirical or Not Conventional Helicobacter pylori Eradication Regimens
JANNIS KOUNTOURAS
doi : 10.1016/j.cgh.2022.10.027
Volume 21, Issue 9, August 2023, Pages 2433-2434
Reply
OLGA P. NYSSEN JAVIER P. GISBERT
doi : 10.1016/j.cgh.2022.11.007
Volume 21, Issue 9, August 2023, Pages 2434-2435
Letter to the Editor: Nonalcoholic Fatty Liver Disease Without Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome
TOMOYUKI KAWADA
doi : 10.1016/j.cgh.2022.10.034
Volume 21, Issue 9, August 2023, Page 2435
Reply
DONG HYUN SINNDANBEE KANGELISEO GUALLAR
doi : 10.1016/j.cgh.2022.11.035
Volume 21, Issue 9, August 2023, Pages 2435-2436
Hybrid Endoscopic Submucosal Dissection for Early Gastric Neoplasms: An Ideal Technique?
MITSURU ESAKI YOSUKE MINODAEIKICHI IHARA
doi : 10.1016/j.cgh.2022.11.009
Volume 21, Issue 9, August 2023, Pages 2436-2437
Reply
factors MITSURU ESAKI YOSUKE MINODAEIKICHI IHARA
doi : 10.1016/j.cgh.2022.12.004
Volume 21, Issue 9, August 2023, Pages 2437-2438
Comment on "Food Processing and Risk of Crohn’s Disease and Ulcerative Colitis: A European Prospective Cohort Study"
YUYA ANDOTOSHIFUMI YODOSHITAKASHI YOSHIOKA
doi : 10.1016/j.cgh.2022.11.018
Volume 21, Issue 9, August 2023, Pages 2438-2439
Reply
ANTOINE MEYERMARIE-CHRISTINE BOUTRON-RUAULTFRANCK CARBONNEL
doi : 10.1016/j.cgh.2022.12.027
Volume 21, Issue 9, August 2023, Page 2439
